Nongfu Spring: Tea Overtook Water Back in 2024 and Now Supplies 52% of Segment Profit, While HK$42.40 Sits 12% Above Conservative Value

Yet the decomposition investors most want cannot responsibly be supplied. Nongfu does not disclose packaged-water litres sold, segment ASP, or distributor gross margin. Its financial reports provide revenue, product commentary and segment profit, but no price-volume bridge. An exact statement such as "volume grew X%, ASP fell Y%" would be fabricated. The strongest inference the public data support is that the company probably gained volume/value share while industry price/mix weakened; the relative contribution of Nongfu-specific volume, list price, promotional discount and packaging mix is unobservable from disclosed data. Company and industry reporting also indicate management restricted disorderly online discounting to protect offline pricing, but distributor profit per case is not disclosed.

Tea has the opposite problem: exceptional economics married to a category whose earlier hyper-growth is normalising. Oriental Leaf is no longer merely a large player. Mashangying retail-monitoring data quoted in 2026 industry reporting put its Q2 2026 share of monitored sugar-free tea sales at 86.79%, up 7.56 percentage points year on year, with Suntory at 3.85%, Tingyi at 2.41%, Guozishule at 2.28% and Chunfu at 1.19%. This measurement should not be confused with audited national volume share: it is retail-monitoring data from Mashangying's sample and different methodologies can produce lower 70–75% estimates.

The category trajectory is more nuanced than "sugar-free tea is slowing, so Nongfu tea must slow." China sugar-free tea grew at about a 33% CAGR from 2017 to 2022 and reached roughly RMB7.2 billion in 2022 according to industry material; retail-monitoring commentary describes an explosive 2023–early-2024 phase, followed by marked deceleration during the 2025 peak season. Mashangying data cited by CBNData say every month from April through September 2025 grew more slowly than the corresponding 2024 month, while separate industry analysis says monitored sugar-free tea sales moved into negative growth during 2025. At the same time, Oriental Leaf kept taking share.

That is the bull case in one sentence: category growth can slow sharply while the category leader continues to compound through share gains, format expansion and distribution. H1 2026 gives evidence for that interpretation. Tea segment revenue still grew 30.1%. Oriental Leaf added 335ml and 900ml white-tea formats and a refrigerated Cold Extracted Longjing product; Tea π reduced sugar by more than 25% across its reformulated line. The chilled Longjing product entered Sam's Club with a cold chain and spent several months near the top of its relevant bestseller rankings.

The bear case begins where the bull case ends. An 80%-plus share is mathematically difficult to keep gaining from. The brand is becoming increasingly important to group profit at precisely the point when category growth is no longer giving every participant a free tailwind. If Oriental Leaf's growth falls from 30% toward low teens, Nongfu's valuation will become dependent on whether water can reaccelerate, whether functional drinks can become a larger second engine, and whether the company can hold margins above 60%.

Those margins are genuinely unusual. H1 2026 gross margin was 60.9%, up 0.6 percentage point despite higher PET resin costs, because product mix and lower juice and sugar procurement costs offset the headwind. Selling and distribution expense was 19.7% of revenue, almost unchanged; advertising and promotion rose while logistics cost benefited from mix. Administrative expense fell to 3.8% of sales. Net profit attributable to owners was RMB8.887 billion on RMB29.718 billion revenue, a net margin just under 30%.

The longer financial record validates the quality screen, though my recomputation does not exactly reproduce every input of our Buffett quality screen's 89/100 score. From 2021 through 2025 revenue rose from RMB29.696 billion to RMB52.553 billion, about 15.3% annualised, while net profit rose from RMB7.162 billion to RMB15.868 billion, about 22.0% annualised. Average gross margin over those five years was about 59.0%. Using average opening and closing equity, ROE averaged about 42% over 2022–2025. The company ended H1 2026 with RMB26.534 billion of cash, deposits and related cash balances against RMB5.186 billion of interest-bearing borrowings.

The balance sheet is not the investment problem. Competitive durability and price are.

At HK$42.40, the stock is valued at about RMB408.5 billion of equity using the September 4 exchange rate. That is 25.7 times 2025 net income, roughly 23.8 times trailing earnings using H2 2025 plus H1 2026, and approximately 22.3 times my RMB18.3 billion central 2026 profit estimate. The stock is well below its January 2021 all-time high of HK$68.76 but well above the September 2024 low of HK$23.56. A fall from an old peak is not itself undervaluation.

My SOTP values the slower water franchise separately from tea. Under the central case I attribute about HK$108 billion of operating value to water, HK$293 billion to tea and roughly HK$97 billion to functional drinks, juice and other products, then add about HK$25 billion of narrow net cash. That produces approximately HK$46.5 a share. The conservative and optimistic equivalents are roughly HK$37.7 and HK$55.4. Those values deliberately give tea a substantially larger share of enterprise value than water because current segment growth, profitability and category position justify it.

That does not make today's price a bargain. The current quote is already about 12% above my conservative intrinsic-value case. A reasonable investor can own a business of this quality around fair value, but the capital-loss protection is weak if Oriental Leaf's exceptional segment economics normalise at the same time as bottled-water price competition persists.

The qualitative portrait comes out as company in transition, with high-quality compounding economics underneath it. The transition is from a water-defined brand to a tea-led beverage earnings model. Its outcome depends less on whether Nongfu can sell more bottles in aggregate than on whether Oriental Leaf can remain extraordinarily profitable after sugar-free tea ceases to be an extraordinary growth category.

Vertical history and financial evolution

From natural water to a national beverage architecture

Nongfu Spring was founded in Hangzhou in 1996 under Zhong Shanshan, initially around packaged drinking water sourced from China's natural-water resources. The original model was considerably narrower than today's five-segment beverage portfolio. Its early differentiation rested on natural-source water, not the purified-water model used by much of the mass market; over time that choice turned water-source access, factory location and brand language around "natural" water into a coherent commercial system rather than a single product claim. The 2020 prospectus describes packaged water as the foundation from which the company expanded into tea, functional drinks, juice and other beverages.

Competitively, Nongfu grew up against bottled-water brands including Wahaha and C'estbon and later against a broader packaged-drinks industry led by companies such as Tingyi and Uni-President. Its distinguishing operating decision was to invest around water sources and manufacture close enough to those sources to move packaged product nationally without abandoning the natural-water proposition. That model is more capital intensive than buying generic purified water locally, but it created a physical asset network competitors cannot reproduce merely by purchasing advertising.

The second stage was portfolio experimentation. Functional drinks, juice, agricultural products and RTD tea gradually reduced dependence on water. Oriental Leaf, launched in 2011, is the most consequential example. It spent years operating ahead of mainstream Chinese consumer preference for unsweetened tea before the category accelerated. The 2025 annual-report narrative explicitly treats the product as a long-duration investment rather than a recent trend-chasing launch.

That history matters for assessing management. Oriental Leaf's current economics were not purchased in an acquisition or created by one lucky season. Nongfu endured a long period when sugar-free tea was a niche, kept the brand alive, expanded flavours and packaging, and then had a national distribution system ready when consumer preference moved toward lower-sugar beverages.

Listing turned a private consumer franchise into a scarcity asset

Nongfu listed on the HKEX Main Board on September 8, 2020. The global offering initially comprised 388.2 million shares at a price range of HK$19.50–21.50; the final offer price was HK$21.50. Including the over-allotment, approximately 446.5 million shares were sold, and subsequent company reporting records net IPO proceeds of about HK$9.38 billion.

The IPO story was unusually simple for a company with multiple products: investors were buying a dominant Chinese packaged-water franchise with high margins, a founder-owner, national consumer recognition and an underappreciated beverage portfolio. Demand was extreme. The first trading day opened at HK$39.80 and closed around HK$33.10, far above the HK$21.50 offer price.

The early market extrapolated scarcity and quality aggressively. The shares reached an all-time high of HK$68.76 on January 8, 2021. That valuation represented the first major capital-markets phase: Nongfu was treated as a rare high-ROE Chinese consumer compounder with durable water pricing power.

The business then started changing underneath that label.

Tea became the growth engine before the market narrative fully caught up

The half-year reconstruction makes the transition visible more clearly than annual averages do.

The segment values reconcile to group revenue apart from rounding.

The 2022–2023 transition came from tea rather than deterioration in water. H1 2023 water still grew 11.7% as outdoor and on-the-go consumption recovered after pandemic restrictions, while tea grew 59.8%. Tea was simply compounding much faster.

The next turn was different. During January and February 2024, the company says packaged-water revenue was still growing 19% year on year. From late February, a wave of online attacks and negative public commentary hit the brand, and H1 water revenue ended the half down 18.3%. The company simultaneously returned to purified drinking water in April 2024 with a green-label product after roughly two decades of focusing its core brand message on natural water.

This episode coincided with a wider water price war. It revealed two things. First, consumer brands in China can be damaged quickly by social-media narratives even when the product has not changed. Second, Nongfu's portfolio diversification had become large enough to cushion the blow: H1 2024 tea grew 59.5%, leaving total group revenue up despite the water decline.

Full-year 2024 was the strategic inflection. Water revenue was about RMB15.95 billion while tea reached about RMB16.75 billion. The crossover was masked by the reputational explanation attached to water, but it was real. In H1 2025 tea again exceeded water, and in full-year 2025 tea reached RMB21.596 billion versus water's RMB18.709 billion.

The H2 progression reinforces the point:

These values are calculated as audited full-year segment revenue less the corresponding interim figure. The crossover appeared in H2 2024, persisted through H1 2025 and expanded further thereafter.

The 2024 shock was serious, but the recovery exposed the strength of the portfolio

Nongfu suffered a second reputational incident in July 2024 after Hong Kong's Consumer Council discussed bromate in tested bottled water. The company contested the classification basis; the council's own position was that its test had not identified a safety violation. The episode nevertheless hurt sentiment: the Financial Times reported an almost 3% share-price drop around the dispute and an approximately 18% decline over the preceding month amid the broader price war and reputational pressure.

On July 9, 2024, with the shares at HK$33.75 and already down heavily, controlling shareholder Yangshengtang announced a plan to acquire up to HK$2 billion of additional H shares over roughly six months. At that date Yangshengtang held about 66.82% of total shares and Zhong directly and indirectly held approximately 83.98%.

The share price bottomed at HK$23.56 on September 16, 2024. In hindsight, that trough priced more than a normal bad half. It priced a possibility that the reputational damage had permanently impaired a brand whose value depended on consumer trust.

The 2025 accounts argue against that extreme interpretation. Water revenue rebounded 17.3% to RMB18.709 billion; tea grew 29.0% to RMB21.596 billion; group revenue passed RMB50 billion for the first time at RMB52.553 billion. The recovery did not require a return to the old revenue mix. Water repaired; tea remained larger.

The financial record is stronger than the 2024 narrative would suggest

The figures are from the 2025 annual report's five-year summary.

Revenue compounded about 15.3% from 2021 to 2025; attributable profit compounded about 22.0%. Gross margin averaged about 59.0%, above our quality screen's 57.7% because that screen averages over a longer historical window. ROE calculated from average opening and closing equity was roughly 37.9% in 2022, 45.9% in 2023, 39.8% in 2024 and 44.2% in 2025, an average near 42%. The direction of the Buffett-quality score is therefore confirmed even though its 36.6% long-run ROE average cannot be reproduced from the shorter like-for-like public table.

Cash generation also looks real. In 2025 operating cash flow was RMB21.142 billion against RMB15.868 billion of accounting profit, a 1.33 times conversion ratio. Cash spending on property, plant and equipment was roughly RMB6.481 billion and land-use-right spending another RMB0.286 billion, leaving conventional post-capex free cash flow of about RMB14.375 billion. In 2024, operating cash flow had been materially weaker at RMB11.022 billion while capital expenditure remained around RMB6.4 billion; the rebound is one reason 2025 quality was better than the headline revenue recovery alone suggests.

The group is still investing. H1 2026 had RMB3.970 billion of contracted capital commitments for plant and equipment. Depreciation of property, plant and equipment was RMB1.759 billion in the half, with another RMB78 million of right-of-use depreciation and RMB10 million of intangible amortisation. That points to an annual depreciation base around RMB3.5–3.8 billion, well below recent cash capex, implying a meaningful portion of investment is expansion rather than maintenance.

The owner-earnings question needs care. The company does not split maintenance and growth capex. Using depreciation as a rough maintenance proxy gives maintenance spending of roughly RMB3–4 billion annually and growth capex of another RMB3 billion-plus at the current investment rate. That estimate is mine, not management guidance. It fits the physical expansion in water sources and factories better than treating every yuan of capex as maintenance.

Price history tells a story of multiple expansion, brand shock and re-rating

The capital-market path can be divided into four regimes. The first-day surge from HK$21.50 to a HK$33.10 close in September 2020 and the subsequent rise to HK$68.76 in January 2021 were predominantly scarcity and multiple expansion around a high-margin consumer franchise.

The second regime was normalisation. Growth stayed strong, but a valuation built around a nearly untouchable water franchise had less room to expand. By 2023 the operating business was increasingly tea-driven even while market shorthand still treated the company as China's premium bottled-water champion.

The third regime was the 2024 brand and price-war shock. Shares stood at HK$33.75 on July 9, when Yangshengtang announced the HK$2 billion purchase plan, then reached the HK$23.56 historical low in September. The fall coincided with the water-sales disruption, online criticism, the Hong Kong Consumer Council dispute and intensified bottled-water pricing.

The fourth was the 2025 recovery and partial re-rating. In July 2025 the stock traded around HK$46.5 and reached HK$47.4 intraday as investors responded to restored water momentum and continued tea growth. Following the March 2026 annual results, reporting recorded a greater-than-10% intraday rise to above HK$45 as the market digested 22.5% revenue growth, 30.9% profit growth and restored 60%+ gross margins.

H1 2026 then produced a more ambivalent reaction. The stock closed HK$43.04 on August 25, rose 2.4% to HK$44.08 after the results on August 26, then gave most of that back at HK$42.94 on August 27. That response fits a market balancing tea's 30% growth against only 2.1% water growth rather than treating the headline 16% group growth as an unqualified beat.

By September 4 the close was HK$42.40. The stock is thus roughly 38% below the 2021 peak but about 80% above the 2024 trough. Neither comparison answers whether it is cheap. What changed is the composition of the business investors are capitalising.

Business model, moat, governance and industry

The current profit machine

H1 2026 gives the clearest view of the present company.

† Segment-result margin is calculated from the company's adjusted segment result before unallocated head-office and other group items; it is not segment gross margin or attributable net margin.

The exact filing values, in RMB millions, reconcile to RMB29.7181 billion of group revenue.

Three observations follow.

First, tea is now the main profit pool as well as the main revenue pool. Tea's RMB6.406 billion reported segment result in the half was almost twice water's RMB3.257 billion.

Second, functional drinks are economically more important than their 11% revenue share suggests because the disclosed segment margin is high. This gives Nongfu a credible third leg if the functional-drink category continues growing.

Third, the "other" segment remains too small to underwrite a coffee thesis. It includes soda water, coffee, plant-based drinks, fresh fruit and other agricultural products and generated only RMB684 million in H1 revenue.

Why a 60% gross margin is possible

The H1 2026 income statement is exceptional for a mass beverage manufacturer: RMB18.099 billion gross profit on RMB29.718 billion revenue, or 60.9%. Selling and distribution took RMB5.843 billion, 19.7% of sales; administration was RMB1.125 billion, 3.8%; profit attributable to owners of the company was RMB8.887 billion.

The margin has both structural and cyclical pieces.

The structural part begins with mix. Water is cheap to formulate but expensive to package and transport relative to the value of its contents. High-value tea, functional drinks and juice carry more ingredient cost but much higher revenue per bottle, and the H1 segment table shows tea monetises this far better than water after production and distribution. As tea becomes a greater share of revenue, group margin can rise even if individual product economics are unchanged.

The second structural element is production around natural-water sources. As of H1 2026 Nongfu reported 17 major natural-water sources across China, including Qiandao Lake, Danjiangkou, Changbai Mountain, Wuyi Mountain and newer sites around Jiaozi Snow Mountain and the Leiqiong volcanic area in Hainan. Two sources were added during the latest half.

The evidence supports source access as a moat, but not every version of the moat story. The company does not disclose current source-by-source economic capacity in a format that permits an investor to compare cubic metres of low-cost usable water with competitors. Nor should "17 sources" be conflated with outright private ownership of a natural resource; the relevant assets are source access, permits, adjacent factories and sunk distribution infrastructure.

PET resin is cyclical. In H1 2026 higher PET costs were a margin headwind. Lower sugar and juice-material procurement and better product mix more than offset it. In 2025 the opposite commodity configuration had been unusually helpful: lower PET, carton and sugar procurement contributed to the jump in gross margin from 58.1% to 60.5%.

Advertising is discretionary but strategically difficult to cut. H1 2026 advertising and promotional spending increased, while total selling and distribution stayed around 19.7% of sales because logistics expense improved with mix. That is a real operating-leverage benefit from tea: a higher-value bottle can carry similar physical distribution cost while generating more gross profit.

R&D is not a conventional moat here. H1 R&D expense was only RMB144 million, less than 0.5% of sales. Nongfu innovates through consumer insight, formulation, packaging, supply-chain engineering and brand persistence rather than research intensity in the pharmaceutical or semiconductor sense.

The strongest margin moat is the interaction of brand, product mix, source-linked manufacturing and national distribution; PET and sugar tailwinds are cyclical bonuses, not the moat itself.

If bottled-water price competition persists for another two years, my stress case assumes water net realisation/mix falls about 5% cumulatively with no proportional raw-material relief. Because water is roughly one-third of sales, that by itself could take around one percentage point or somewhat more from group gross margin; additional trade promotions could depress operating margin another 0.5–1 percentage point. Tea mix could offset part of the damage. A reasonable two-year stress outcome is therefore 58–59% group gross margin, not a collapse into the 40s. That is a valuation assumption, not company guidance.

Water's volume, price and channel economics: what can and cannot be established

The most important missing disclosure in this research is also the one investors most need: Nongfu does not publish water volume and ASP separately.

The industry data are more informative. NielsenIQ figures cited in 2026 reporting show H1 Chinese packaged-water volume down 4.9% and sales value down 7.3%. Dividing the two suggests category sales value per unit declined roughly 2.5%. Nongfu's own water revenue rose 2.1%.

That establishes relative resilience. It does not establish whether Nongfu's litres grew 5% while ASP fell 3%, whether litres grew 2% with flat net realisation, or whether pack-size mix did the work. Any precise decomposition would exceed the evidence.

There is one useful historical clue. H1 2024 management said water revenue had been up 19% in January and February before the reputational shock hit from late February. H1 2025 then rebounded 10.7%, and FY2025 rose 17.3%. The sequence makes the H1 2026 +2.1% rate partly a difficult recovery base: it is measured against an already normalising H1 2025, not the depressed H1 2024 trough.

Channel economics are similarly opaque. Industry reporting says Nongfu deliberately constrained disorderly low-price e-commerce sales in 2025 to reduce conflict with offline distributors. This fits the 2025 gross-margin recovery and the company's long-standing reliance on offline availability, but no public filing gives distributor gross margin per case or retailer margin by SKU.

The relevant investment conclusion is therefore narrower: Nongfu protected revenue better than the packaged-water category in H1 2026, but public disclosure is insufficient to prove that its water pricing power has fully recovered.

The distribution moat is real, but today's disclosure is less granular than investors might like

The IPO prospectus described a nationwide network of more than 4,000 distributors and around 2.4 million terminal retail outlets at the time of listing. That scale helped Nongfu push new categories through an already established physical network.

The company has not continued publishing a directly comparable current point-of-sale number at the same level of granularity. That creates a limitation in proving the popular claim that the distribution moat has continuously widened. What can be demonstrated is the economic output: the same network carried water through a reputational shock, took the tea segment from H1 2022 revenue of RMB3.3 billion to RMB13.1 billion four years later, and supports multiple pack sizes and chilled products.

Cold chain is a targeted capability, not the entire logistics model. In 2025 the company put a 900ml chilled TANBING black coffee product into Sam's Club; in 2026 it added chilled Cold Extracted Longjing tea with end-to-end cold-chain requirements. This is evidence that Nongfu can operate refrigerated niches, but it should not be exaggerated into a claim that its whole national logistics system is company-owned refrigerated infrastructure.

Oriental Leaf is now the moat that matters most

Oriental Leaf's moat is partly category leadership and partly brand architecture. A leading share of 86.79% in Mashangying's Q2 2026 monitored sample is unusually high. The figure also implies that the next move in share is far more likely to be normalisation than further gains: mathematically, little unconquered category remains in that measurement universe.

The product architecture is becoming broader. H1 2026 brought 335ml and 900ml white-tea sizes, limited Longjing products and chilled Cold Extracted Longjing. Multiple sizes increase shelf frontage and address different consumption occasions without requiring a separate master brand.

That strategy also creates a concentration risk. Nongfu reports only the tea segment, not Oriental Leaf sales separately. Industry evidence strongly indicates Oriental Leaf dominates the segment, while Tea π is the secondary sweetened-tea franchise. The group's largest business is economically much more concentrated in one master brand than the five reported segment labels imply.

Sugar-free tea has moved from category land-grab to share-consolidation

Industry evidence supports a decelerating category, but the quality of the available time series varies. A market overview put Chinese sugar-free tea at roughly RMB7.2 billion in 2022 after approximately 33% annual growth from 2017. Retail-monitoring commentary then described the 2023–early-2024 period as explosive expansion. By the 2025 peak season, Mashangying data showed clear deceleration: every month from April through September grew more slowly than the year-earlier comparable, and several months grew at less than half the prior-year rate.

One 2025 industry study described sugar-free tea sales in its monitored universe as entering outright negative growth. The methodology and coverage are not identical to every other share series, so I would not turn that into a national audited market-growth figure.

What is robust is the direction: the category has passed its easiest hyper-growth phase.

The tea segment's 30.1% H1 2026 growth alongside a rising monitored share suggests Nongfu is currently outrunning the category by taking more of the profit pool. That is a stronger competitive outcome than merely growing with the market, but it also makes future comparisons harder.

Coffee is an experiment, not yet a second growth curve

The 2026 distributor strategy around RMB5 coffee can be verified.

In May 2025 Nongfu launched a 900ml refrigerated, sugar-free TANBING black coffee product at Sam's Club. In November the company added 400ml classic black coffee and latte products produced from roasted beans at its own roasting facility. Distributor-conference reporting says the 400ml unsweetened Americano and low-sugar latte were positioned at RMB5, with management highlighting that price point as a 2026 priority alongside strengthening water and scaling sugar-free tea.

The addressable consumer occasion is obvious: RMB5 RTD coffee sits below most freshly made branded coffee while retaining convenience-store distribution. The financial evidence remains tiny. Coffee is embedded in the RMB684 million H1 2026 "other" segment with soda water, plant-based drinks and agricultural products. No separate sales, gross margin, unit volume or marketing budget is disclosed.

Funding is likewise not separately disclosed. Group advertising and promotion increased in H1, but attributing a specific amount to coffee is impossible. For valuation I assign virtually no incremental option value to the RMB5 strategy beyond the current "other" segment earnings.

Governance deserves a real minority-shareholder discount

The latest annual-report ownership table revises the most widely quoted control figure slightly. At the 2025 year-end/latest practicable date, Yangshengtang controlled 6.2118 billion domestic shares and 1.310252 billion H shares, around 66.88% of total capital. Zhong Shanshan additionally held 1.929249 billion H shares personally. Taken together, his deemed direct and indirect interest was about 84.04%, slightly above the 83.98% level reported before Yangshengtang's additional purchases.

Yangshengtang itself is effectively wholly controlled by Zhong: the annual report states he owns 98.38% directly and another 1.62% through wholly owned Hangzhou Youfu.

The same annual report identifies Beijing Wantai Biological Pharmacy as an associated controlled corporation: Zhong held 17.71% directly and 55.82% through Yangshengtang, a combined 73.53%.

This does not mean assets or cash are interchangeable between Nongfu and Wantai. It means minority investors are exposed to a controller with substantial outside corporate interests.

Public float is unusually low. The April 2026 annual report calculates 1.784981 billion shares as public, 15.87% of Nongfu's total capital. HKEX granted a waiver under which the minimum required public float is the higher of approximately 13.66% of total capital and the post-offering public-H-share percentage of 14.11%. At the September 4 price, public float represents only about HK$75.7 billion of tradeable market value despite a HK$476.9 billion headline market capitalisation.

Low float has three consequences. It reduces free-float-adjusted market capitalisation relative to headline size, concentrates price discovery in a much smaller portion of the company and makes shareholder transactions by the controller more important to supply. It does not automatically prevent index eligibility, but a free-float-adjusted index will naturally treat the company as much smaller than its headline equity value.

Related-party transactions also merit attention. The annual report expressly directs investors to Note 36 and the continuing-connected-transaction section and notes Yangshengtang-group IT services among historical arrangements. It says there were no other significant contracts with the controller outside the disclosed connected transactions. The available public extracts do not permit me to reconstruct every 2025 related-party category and annual-cap utilisation reliably, so I treat that as a research blind spot rather than asserting immateriality.

Capital allocation has otherwise been shareholder-friendly. The 2025 final dividend was RMB0.99 per share, about RMB11.134 billion in aggregate, paid in August 2026. The company also spent about RMB222 million on repurchases during 2025 while continuing substantial factory investment.

Horizontal competitor analysis

Nongfu operates in a market with enough listed peers to avoid pretending it is unique, but none reproduces the same mix. The useful comparison is ecological, not mechanical.

Tingyi is the broad national beverage-and-noodle scale incumbent. Its advantage is category breadth and physical distribution, not Nongfu-like margins. H1 2026 consolidated revenue was RMB40.545 billion. Tingyi's beverage gross profit was RMB10.184 billion at a 38.4% beverage gross margin, implying roughly RMB26.5 billion of beverage sales.

Uni-President China is another national food-and-beverage operator with much lower operating margins than Nongfu. Its H1 2026 presentation reported a 35.0% group gross margin and 10.4% operating margin. Its beverage franchise is meaningful but its economics remain those of a diversified mass-market packaged-food company, not a premium-margin beverage pure play.

Eastroc Beverage represents a different threat. Its historical success has come from exceptional route-to-market execution in functional drinks and a willingness to reuse that network across new beverages. Industry reporting around its 2026 launches describes a network exceeding four million outlets and an aggressive entry into low-priced sugar-free tea, including RMB3 products aimed below Oriental Leaf's mainstream price architecture. That makes Eastroc strategically relevant even before its tea revenue approaches Nongfu's.

China Resources Beverage, through C'estbon, is the closest pure packaged-water comparison because its profit pool overlaps directly with Nongfu's water shelf space. Its existence is a reminder that natural-source narrative and national distribution do not create monopoly economics: purified water can compete on ubiquity and price.

Luckin is relevant only to the new coffee experiment. A RMB5 bottled coffee competes with convenience-store RTD coffee and indirectly with the lower end of freshly prepared coffee pricing. Nongfu can use a packaged-goods cost structure and existing distribution; Luckin competes through stores, app traffic and a freshly prepared product. The two models will not earn the same gross margin or require the same capital, so Luckin is a strategic reference rather than a direct valuation peer.

The global beverage names Coca-Cola, PepsiCo and Monster Beverage are useful in another way: they show what markets are willing to capitalise when brands, distribution and high cash conversion persist for decades. Nongfu's margin profile is strong enough to deserve comparison, but its concentrated controller, China-only demand exposure, lower free float and tea-category concentration justify a discount to the cleanest global franchise valuations rather than an automatic global-staples premium.

The closest operating figures available on a common H1 2026 basis illustrate the economics.

† Tingyi's cited interim extract gives beverage gross margin rather than a directly comparable beverage operating margin.

Sources are the companies' H1 2026 filings and presentations.

The main horizontal conclusion is striking. Nongfu does not win because it has the highest revenue. It wins because each yuan of beverage revenue currently throws off far more gross and operating profit than the large mass-market peers. Tea has amplified that difference.

Nongfu's real niche is the high-margin brand-and-distribution owner inside China's mass packaged-beverage market. Tingyi and Uni can match or exceed physical scale in parts of the market; Eastroc can challenge channel execution; C'estbon can pressure water price. None currently combines Oriental Leaf's sugar-free tea share with Nongfu's 60% group gross margin.

That advantage can weaken in two ways. A price war attacks the monetisation side of the moat. A successful competing sugar-free tea attacks the brand side. The first is already happening in water; the second is the larger three-to-five-year risk because tea now carries more enterprise value.

Current fundamentals, price narrative and risks

H1 2026 was strong at group level and less comfortable underneath

Revenue was RMB29.718 billion, up 16.0%; attributable profit was RMB8.887 billion, up 16.6%; EPS was RMB0.790. Gross profit rose to RMB18.099 billion and gross margin reached 60.9%.

The balance sheet remained conservative. Cash, bank balances, long-term deposits and restricted/pledged deposits totalled RMB26.534 billion at June 30, up 19% from December. Interest-bearing borrowings were RMB5.186 billion. Inventory was RMB6.214 billion with 94.7 days of turnover, little changed from 95.5; trade receivables were only RMB901 million with 4.5 days of turnover.

Those receivable numbers matter. They show a consumer-products company that generally gets paid quickly, not one manufacturing accounting growth through distributor credit.

The weak line is water. +2.1% growth would look acceptable in a mature beverage business if tea were not growing 30% and if investors did not historically capitalise Nongfu partly on water's pricing power. At the same time, national water volume and sales value were declining, so Nongfu's relative outcome was considerably better than its absolute growth number implies.

The strong line is tea. H1 revenue grew 30.1%, added RMB3.033 billion year on year and accounted for most of the group's incremental revenue. Functional drinks and juice supplied useful mid-teens growth but are not yet large enough to offset a major Oriental Leaf slowdown.

What the market is trading now

The market is no longer principally trading "China bottled-water penetration." It is trading three variables simultaneously.

The first is Oriental Leaf duration: can a dominant sugar-free tea franchise keep growing 20%+ after category growth slows?

The second is water normalisation: does +2.1% mean market-share resilience in a weak category or the beginning of a structurally ex-growth franchise?

The third is margin durability: can tea mix keep group gross margin around 60% if water discounting and PET costs remain unfavourable?

The sharp analyst-target dispersion after H1 2026 is revealing. Publicly aggregated targets included roughly HK$32 at the bearish end and HK$60 at the bullish end immediately after the results. That is too wide a range for disagreement about a few basis points of expense. The market is assigning very different terminal growth and multiple assumptions to tea and water.

The bull and bear cases rest on different readings of the same numbers

Bulls can point to water outperforming a falling category, tea adding share while its category slows, a gross margin above 60%, almost no balance-sheet risk and founder ownership that strongly links Zhong's wealth to the stock. The operational evidence for those claims is substantial.

Bears can point to the same tea data and reach a different conclusion. A monitored share above 80% has less room to rise. Group profit concentration is higher than revenue-segment labels imply. Water is growing low single digits after a price war, and the company does not provide the ASP/volume disclosure needed to prove its pricing power remains intact. Meanwhile, the stock still trades at roughly 24 times trailing profit despite these uncertainties.

I lean toward the first interpretation on business quality and toward the second on margin of safety.

Permanent-loss risks

The largest risk is tea growth normalisation. I assign it medium-to-high probability and high impact. If Oriental Leaf's revenue growth falls below 10–12% while monitored share starts dropping from the mid-80s toward the 70s, the market can simultaneously reduce earnings forecasts and the multiple assigned to the segment. Because tea is already more than half of H1 segment profit, this transmission path can cut group profit growth much faster than its 44% revenue weight implies. The observable indicators are tea segment growth, Mashangying share and selling-expense intensity.

The second is prolonged water price competition. Probability is medium-high; impact is medium to high. NielsenIQ's H1 category data already show value falling faster than volume. A further two years of low-price purified-water competition could turn Nongfu's water franchise from a high-return channel anchor into a low-growth cash generator requiring more promotion. Watch water revenue relative to category value growth, group gross margin and the selling-and-distribution ratio.

The third is a reversal in raw-material costs. Probability is medium and impact medium. 2025 benefited from lower PET, carton and sugar costs; H1 2026 PET had already moved the other way. A PET upcycle coinciding with water discounting would remove the commodity cushion exactly when the company needs it.

The fourth is founder and reputation concentration. Probability of another material controversy is impossible to estimate cleanly, but impact is high because 2024 proved the transmission mechanism. Online narratives hit water sales within weeks; the shares ultimately fell to HK$23.56. Zhong's approximately 84.04% economic control, a 15.87% public float and outside interests including Wantai increase the governance weight attached to one individual.

The fifth is multiple compression. Probability is medium-high; impact is high. At roughly 24 times trailing profit, Nongfu is not priced for distress. A move toward 18–20 times earnings following tea deceleration could overwhelm several years of ordinary earnings growth even if the business remains profitable.

Food safety is a lower-probability but high-impact tail. The 2024 Hong Kong episode did not identify a safety breach, yet the share-price reaction illustrates how rapidly perceptions can change. New Chinese food-safety measures are scheduled to take effect from December 1, 2026, according to the company's interim discussion.

Financial distress is not a serious present risk. Cash and deposits exceed borrowings by more than RMB21 billion on a narrow definition, receivable days are negligible and the company remains highly profitable.

Valuation, catalysts, cross-synthesis and sources

Cash-flow passthrough and owner earnings

The cleanest recent full-year cash-flow test is 2025. Operating cash flow of RMB21.142 billion was 1.33 times attributable profit of RMB15.868 billion. After RMB6.481 billion of PP&E additions and RMB286 million of land-use-right spending, conventional FCF was about RMB14.375 billion.

A strict five-year OCF/net-income ratio cannot be reconstructed to the same standard from the extracted filing tables available for this report, so I will not invent one. The 2024–2025 pair shows why a multi-year average matters: 2024 OCF was only RMB11.022 billion, while 2025 jumped to RMB21.142 billion. Working capital and payment timing can move sharply even in a high-quality consumer business.

Maintenance capex is also not reported separately. My central owner-earnings convention uses roughly RMB3–4 billion annual maintenance investment, close to the present depreciation run rate, and treats the excess of recent RMB6–7 billion cash capex as growth investment. H1 depreciation data and the RMB3.970 billion of open capital commitments support the view that the company remains in expansion mode.

On that basis, owner earnings are not more than 30% below accounting earnings; the usual reason for such a gap at Nongfu is discretionary expansion investment rather than a structurally capital-hungry maintenance requirement. So I use normalised earnings in the SOTP and test free-cash-flow yield separately.

At HK$42.40, whole-company equity value is about RMB408.5 billion. 2025 FCF yield is only about 3.5%, equivalent to roughly 28.4 times 2025 conventional FCF. Trailing accounting P/E is about 23.8 times. The cash-flow basis is thus less attractive than the headline earnings multiple, although the gap partly reflects growth capex.

Historical valuation

Current trailing P/E around 24 times is far below the IPO-era exuberance that accompanied the January 2021 HK$68.76 peak, and much closer to the post-2024 de-rated regime. I would describe it as roughly lower-third territory within the broad post-listing valuation regime, but that is a regime judgment rather than a statistically computed daily percentile.

The reason the valuation centre moved is fundamental as well as stylistic. Water deserves less of a scarcity premium after the 2024–2026 evidence on competition. Tea deserves more value because it has become the largest business and earns better segment economics. Applying one historical group P/E to both shifts hides the change.

A segment valuation puts most of today's enterprise value in tea

My FY2026 central revenue build is approximately RMB60.0 billion: about RMB19.3 billion water, RMB26.9 billion tea, RMB6.6 billion functional drinks, RMB5.8 billion juice and RMB1.4 billion other. This assumes H2 water grows about 4% year on year, tea about 20%, functional drinks and juice around low teens and other products mid-single digits. Those are research assumptions, not guidance.

I normalise H1 segment-result margins for central corporate cost and tax instead of capitalising the raw 48.8% tea segment margin. The resulting approximate attributable-equivalent earnings used in the SOTP are RMB4.2 billion for water, RMB9.0 billion for tea, RMB2.0 billion functional, RMB1.4 billion juice and RMB0.3 billion other. These are segment-level normalised figures, not a forecast of group net profit, and they are capitalised alongside a separately added net cash balance; they therefore do not tie to the RMB18.3 billion FY2026 group estimate above.

The multiples deliberately diverge.

The narrow net-cash figure uses H1 cash/deposit balances less interest-bearing borrowing and excludes any aggressive valuation of other financial investments. Inputs come from the H1 2026 balance-sheet disclosure and September 4 FX.

At the base multiples, the SOTP breaks down approximately as follows:

The answer to the central valuation question is now explicit: I value the water operating franchise at roughly HK$89–128 billion, with HK$108 billion as the central case. Tea is worth roughly HK$230–356 billion, with HK$293 billion centrally. Water therefore contributes only about one-fifth of operating SOTP value in my base case despite supplying almost one-third of H1 revenue. Tea supplies about 73% of the operating value of water plus tea combined.

That is not a statement that water has become a poor business. A 22x earnings multiple for a low-single-digit-growth beverage segment is still generous. It reflects high cash generation, brand and distribution value. The lower relative weight comes from tea's growth and much higher reported segment profitability.

Scenario analysis

These return ranges include an assumption of ongoing dividends rather than representing management guidance. This is valuation-scenario analysis within a research framework, not investment advice.

The central assumptions are intentionally less aggressive than H1 2026 actual tea growth. I do not capitalise 30% indefinitely.

Expectation gap

The stock at HK$42.40 appears to price a tea business that remains structurally superior but slows, plus a water franchise that stabilises rather than returns immediately to its old premium-growth trajectory.

The next major expectation gap is likely to come from tea, not group revenue. A 15% group result composed of tea at 10% and water at 20% would deserve a different multiple from the same 15% generated by tea at 25% and water near zero, because tea currently has far greater marginal profitability.

The market should care most about four figures at the next report: tea growth, water growth, gross margin and selling expense as a percentage of revenue. Oriental Leaf share data can provide an earlier read on the first figure.

Margin-of-safety recheck

Current price is above the HK$37.7 conservative intrinsic-value case by about 12%. On that definition, the margin of safety is zero.

The most fragile central assumption is the capitalised value of tea. My base SOTP assigns it a 28x multiple on roughly RMB9 billion of normalised segment-related earnings. If the tea valuation component is cut to 70% of that assumption while all other pieces remain unchanged, base fair value falls from HK$46.5 to about HK$38.7 per share.

That sensitivity matters more than fine-tuning water by one or two turns of P/E.

If group earnings were completely flat for three years and the share multiple remained unchanged, shareholder return would primarily be the dividend yield, around 3% at present payout economics. That is positive but inadequate compensation for a concentrated consumer-franchise risk if the market eventually de-rates the stock. The 2025 RMB0.99 dividend represented a substantial payout, but a flat-profit scenario would turn Nongfu from a compounder into a bond-like equity without bond-like capital certainty.

Margin-of-safety sufficiency verdict: none.

This is close to the classic "good company, ordinary price" problem. The company is good enough that waiting carries opportunity cost: Oriental Leaf could continue taking share and fair value could compound away from a patient buyer. The present quote nevertheless does not protect against the scenario in which tea merely becomes normal.

Catalysts and tracking dashboard

Positive catalysts would be water revenue returning to mid-single-digit growth while national category value remains negative; tea remaining above 20% after the 2026 high base; gross margin staying at or above 60% despite PET; evidence that functional drinks become a larger profit pool; and further shareholder purchases or repurchases without weakening float.

Negative catalysts would be Oriental Leaf share loss, tea growth below the low teens, water revenue turning negative, a rise in selling expense without matching revenue growth, gross margin dropping below 58%, or a controlling-shareholder disposal that materially expands free float because the market may read it as an information signal as well as new supply.

Current operating references are from the H1 report; Oriental Leaf share is Mashangying's monitored Q2 figure; the next annual-report date is a market-calendar estimate, not a company-confirmed board date, and could change.

Cross-synthesis: what has Nongfu actually proven?

Vertically, Nongfu has proved something more valuable than an ability to dominate bottled water. It has proved that it can take a physical consumer-goods distribution system built around one high-frequency product and use it to incubate a second franchise whose economics eventually surpass the first.

Oriental Leaf is the strongest evidence. It was launched in 2011, long before sugar-free tea became the growth category it is now. That persistence weakens the argument that Nongfu simply rode a fashion. The fashion eventually arrived; management had a product, a brand, factories and shelf access waiting for it.

The second proven capability is margin discipline. Over 2021–2025 gross margin averaged about 59%, while net margin rose from 24% to 30%. This survived pandemic disruption, commodity movements, a brand crisis and an increasingly competitive bottled-water market. A margin that survives adverse environments deserves more respect than one observed only during a commodity trough.

The third is balance-sheet conservatism. Nongfu has not needed leverage to manufacture its ROE. H1 cash and deposits exceeded interest-bearing debt by more than RMB21 billion on a narrow definition. High returns therefore come from asset productivity, brand economics and negative/low working-capital intensity, not financial engineering.

Past success nevertheless included favourable era effects. Urbanisation, convenience retail, higher bottled-beverage penetration and health-oriented consumer preferences all helped. More recently, the shift away from sugar toward unsweetened beverages gave Oriental Leaf an extraordinary category tailwind. Management deserves credit for being positioned before the tailwind, but investors should not extrapolate the tailwind itself indefinitely.

Horizontally, the company's largest advantage is not any single water source. It is the combined system. Tingyi can match scale, C'estbon can compete directly in water, Eastroc can match aggressive distribution, and new tea brands can undercut Oriental Leaf. Nongfu's defence is that a competitor has to attack several things at once: a highly recognised tea brand, national shelf access, a source-linked water identity, substantial advertising capacity and a balance sheet capable of funding a long product war.

The moat is stronger in tea today than water. This statement would have sounded strange at IPO, but the segment figures require it. Tea's H1 adjusted segment margin is almost 49%; water's is about 34%. Tea's monitored sugar-free share is above 80%; water operates in a category currently experiencing value and volume contraction.

Water's weakness is partly temporary. The 2024 collapse clearly included an unusual reputational shock, and 2025's 17.3% rebound proves consumers did return. H1 2026 water also outgrew the wider category materially.

Its slower growth is partly structural as well. Mature packaged water has lower category growth, more transparent price comparison and credible national competitors. The company itself has re-entered purified water, which broadens its addressable market but also acknowledges that the premium natural-water story alone is no longer enough to control every price tier.

That distinction shapes what the stock is worth. I do not value water as impaired. At 22x normalised segment earnings in the base SOTP, it receives a premium mature-consumer multiple. But I will not give a 30x+ multiple to a business currently growing 2% just because its historical identity once justified one.

Tea earns the larger valuation, but even there 28x central earnings is enough. A 30%-growing brand with nearly 50% disclosed segment-result margin could superficially support more. The reason to stop at 28x is category mathematics. A share already above 80% cannot take unlimited share, and monitored category growth has slowed.

The market's probable misjudgment is two-sided. Bears who still analyse Nongfu chiefly as a wounded water company understate the magnitude and profitability of the tea transformation. Bulls who value the whole group as though Oriental Leaf can repeat its 2022–2026 growth curve understate category saturation.

The next year is about whether tea can stay above roughly 20% and whether water moves from 2% toward mid-single digits without buying that growth through price.

The next three years are about whether Oriental Leaf becomes a durable Chinese staple brand rather than the dominant winner of one category cycle. The key signal will be the combination of share and margin. A fall from 86% to 70% would be tolerable if the category expands and revenue keeps compounding; a fall accompanied by low-single-digit category growth would be much more serious.

The next five years are about portfolio replication. Functional drinks already produce unusually good reported segment economics, juice is growing double digits, and coffee gives management another product laboratory. Nongfu does not need TANBING to become Luckin. It needs one or two additional products that can use the same route-to-market with Oriental Leaf-like patience.

Core bull reasons

• H1 2026 tea revenue was RMB13.122 billion, grew 30.1% and produced a 48.8% adjusted segment-result margin, making it both the largest revenue segment and the largest reported segment profit pool.
• Oriental Leaf's Mashangying-monitored Q2 2026 sugar-free tea share reached 86.79% even as the category moved past its easiest growth phase, evidence of share consolidation rather than simple category beta.
• Packaged water grew 2.1% while reported national category volume fell 4.9% and value fell 7.3%, indicating meaningful relative resilience despite absolute sluggishness.
• H1 gross margin reached 60.9%, net margin was about 30%, and cash/deposits exceeded interest-bearing debt by more than RMB21 billion.
• The 2024 reputational shock did not permanently destroy water demand: FY2025 water revenue recovered 17.3%.

Core bear reasons

• Water supplied 32.4% of H1 revenue but grew only 2.1%, and the company does not disclose the price-volume split needed to prove pricing power has recovered.
• Tea economics are concentrated in Oriental Leaf at a time when monitored sugar-free tea growth is decelerating; an 80%-plus share leaves limited incremental share to capture.
• H1 tea supplied about 52% of disclosed segment result, making group earnings more dependent on one franchise than the five-segment reporting format suggests.
• Zhong Shanshan controls about 84.04% of the company while public float is only 15.87%, creating a persistent minority-governance and liquidity discount.
• At HK$42.40 the stock remains around 24x trailing profit and above the conservative SOTP, leaving little protection if tea growth and the multiple contract together.

Pre-mortem: how the stock could lose half its value

The first plausible script starts in 2027. Eastroc, Tingyi and other beverage companies continue pushing RMB3–5 sugar-free tea using national distribution. Oriental Leaf's monitored share falls from the mid-80s toward 65–70% over two years. Category sales, already past hyper-growth, expand only low single digits. Nongfu responds with heavier promotion and more small-pack formats. Tea growth falls below 8%, the normalised tea margin drops from today's roughly 49% segment-result level toward the high 30s, while water remains a 0–3% grower. Group earnings flatten around current levels. Investors stop valuing the tea franchise near 28x and capitalise the company around 17–18x. A 30% earnings/margin disappointment combined with a multiple compression of roughly a quarter can readily take the shares into the low-to-mid HK$20s.

The second script starts in water. The RMB1–2 price war intensifies through 2027–2028, PET rises, and Nongfu is forced to choose between shelf share and distributor economics. Water revenue turns negative despite higher litres, group gross margin falls from 60.9% to 56–57%, and selling expense rises above 22% of sales. At the same time Oriental Leaf slows to the low teens instead of compensating. The market reclassifies Nongfu from a high-growth compounder to a mature Chinese staple at 18–20x earnings. Even without financial distress, the share price can approach HK$25–30.

Neither scenario requires bankruptcy, accounting failure or a collapse in Chinese beverage consumption. Permanent loss can come from paying a growth multiple for growth that normalises.

Final research conclusion

Nongfu Spring is a better company today than the "water business slowed to 2%" headline suggests. Tea has become the principal revenue and segment-profit engine, functional drinks provide a credible third earnings pool, gross margin is above 60%, and the balance sheet is unusually strong. The 2024 brand crisis now looks more like a severe but reversible shock than permanent franchise destruction.

The price is less compelling than the business. At HK$42.40, investors are paying roughly 24 times trailing profit for a group where the best segment still grows 30% but its underlying category is slowing, and the historic flagship is now a low-single-digit grower in a price war. My base SOTP is HK$46.5, only about 10% above the market before dividends. That is enough to justify holding a high-quality franchise, but not enough to supply a margin of safety against a material tea normalisation.

My judgment is that Nongfu has successfully made the transition from water champion to tea-led beverage compounder; the unresolved question is whether today's tea economics are durable enough to deserve a renewed premium multiple.

【Company-profile scores】

• Fundamental quality: high
• Growth: high
• Moat: strong
• Financial soundness: strong
• Management credibility: high
• Valuation attractiveness: medium
• Risk level: medium
• Suitable investor type: long-term growth

【Investment rating】

• Rating: Hold
• One-line thesis: Tea now drives most incremental profit and water is resilient, but HK$42.40 offers no discount to conservative intrinsic value.
• Ideal buy price: see dedicated line below
• Acceptable hold price: HK$40–53
• Clearly overvalued price: HK$61 and above
• Current-price classification: acceptable hold
• Whether to wait for a better price: yes. A purchase below HK$30 would provide at least a 20% discount to the conservative HK$37.7 SOTP; waiting risks missing continued Oriental Leaf compounding.
• Target holding horizon: 3–5 years
• Expected annualised return: conservative about 1–3%; base about 7–10%; optimistic about 12–15%
• Max-loss risk: roughly 40–50% in a combined tea-share loss, margin compression and de-rating scenario that takes fair value into the mid-HK$20s
• Reassessment triggers: tea revenue growth below 10%; Oriental Leaf monitored share below roughly 70–75%; group gross margin below 57–58%; selling/distribution expense above 22% of revenue; water revenue negative despite category stabilisation

【Ideal Buy Price】28–30 HKD

Basis: this is at least 20% below the conservative SOTP value of approximately HK$37.7 and therefore allows for both earnings error and multiple compression.

【Valuation Range】

• current: 42.40 HKD (close as of 2026-09-04)
• bear (conservative · ideal buy zone): [28.00, 30.00]
• base (fair · acceptable hold zone): [40.00, 53.00]
• bull (optimistic · above the clearly-overvalued line): [61.00, 66.00]

Research uncertainties

The largest blind spot is packaged-water price-volume disclosure. Public accounts do not provide litres, ASP or distributor margin, so the precise source of H1 2026's +2.1% water revenue cannot be decomposed.

The second is category-data comparability. Mashangying's monitored retail share and growth data are valuable but are not identical to audited total-China sales value or volume; this explains why older sources can show Oriental Leaf around 70–75% while the latest monitored Q2 2026 figure exceeds 86%.

The third is maintenance capex. Nongfu does not separate maintenance from growth capital spending, so the owner-earnings analysis necessarily estimates the split using depreciation, current capex and physical expansion.

The fourth is current distributor coverage. The IPO prospectus provides a granular historical network count, while recent filings emphasise network strength without publishing an exactly comparable current distributor/point-of-sale series.

The fifth is connected transactions. The latest annual report identifies the required related-party and continuing-connected-transaction disclosures, but the public extracts assembled here do not allow every transaction and annual cap to be reconstructed reliably.

Sources

The primary financial source is Nongfu Spring's 2026 interim-results filing, announced August 25, 2026, including the income statement, segment disclosure, margin commentary, liquidity figures and operating review.

Historical segment reconstruction uses the company's 2022, 2023, 2024 and 2025 interim reports filed with HKEX.

Long-term financials, ownership, cash flow, capital allocation and governance use the 2025 annual report and April 2026 shareholder circular.

IPO facts and early business architecture use Nongfu Spring's 2020 listing documents and contemporaneous IPO reporting.

Current share price and market capitalisation are cross-checked against MarketWatch, StockAnalysis and Yahoo historical data for the September 4, 2026 close.

Industry sugar-free tea and packaged-water evidence uses Mashangying and NielsenIQ data as reproduced in current industry reporting; these figures are treated as third-party monitoring data rather than company-reported facts.

The 2024 reputation and Consumer Council episode is cross-checked against the Financial Times and Nongfu's own subsequent interim disclosure.

Peer operating comparisons use Tingyi's and Uni-President China's H1 2026 filings.

Other tickers mentioned

• 0322.HK: Tingyi is the largest relevant Chinese mass-beverage scale comparison and a direct RTD tea competitor.
• 0220.HK: Uni-President China provides a second national RTD beverage and distribution benchmark.
• 605499.SHG: Eastroc Beverage is the most important fast-growing channel challenger in functional drinks and emerging low-priced tea.
• 2460.HK: China Resources Beverage and C'estbon are the closest listed packaged-water competitive reference.
• LKNCY.US: Luckin frames consumer willingness to buy aggressively priced coffee, though its store model differs from Nongfu's RTD coffee.
• KO.US: Coca-Cola frames the global valuation ceiling for a long-duration branded beverage and distribution franchise.
• PEP.US: PepsiCo provides a global diversified beverage and consumer-staples reference.
• MNST.US: Monster Beverage is relevant to high-margin functional-beverage economics.
• 603392.SHG: Beijing Wantai Biological Pharmacy is controlled by Zhong Shanshan alongside Nongfu and is relevant to governance concentration.
• 600600.SHG: Tsingtao Brewery is a broader listed reference for Chinese discretionary consumer demand.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.